Urinary Iodine Concentrations in Cancer Patients

Document Type : Research Articles

Authors

1 Department of General Surgery, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

2 Department of Medical Genetics, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

3 Mother and Newborn Health Research Center, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

4 4Department of Perinatology, School of Medicine, Tehran University Medical of Sciences, Tehran, Iran

Abstract

 
Background: It has been suggested that incidence of some cancers, especially examples in the breast and stomach may be influenced by the iodine intake. However, only few studies are available at present. Therefore, we have conducted the present assessment of iodine status in Iranian patients diagnosed with a malignancy. Materials and Methods: This cross-sectional study was conducted in 85 patients diagnosed with different types of cancer at Shahid Sadoughi Hospital, Yazd, Iran. The method used was based on the Sandell–Kolthoff reaction. Results: The median urinary iodine concentration (UIC) was 17.4 μg/L, with ≤20 μg/L indicative of severe iodine deficiency. According to the WHO/IC C IDD/UNIC EF classification, 88.1%, 7.1% and 2.4% of patients had a UIC Conclusion: The UIC values indicate that Iranian cancer patients were seriously iodine deficient according to WHO/UNIC EF/ IC C IDD, and that this is a suitable index to assess iodine status in Iranians. Daily consumption of salt fortified with iodine or other approaches to increase intake might be effective strategies for prevention or reduction of malignancies.

Keywords

Main Subjects

Asian Pacific Journal of Cancer Prevention
Volume 18, Issue 3
March 2017
Pages 819-821

Files

History

  • Receive Date: 02 March 2017
  • Revise Date: 10 March 2017
  • Accept Date: 18 April 2017

Share

How to cite

Statistics